Correspondence 0001193125-22-283560 from Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070) (NEUP)
Neuphoria Therapeutics Inc. (NEUP) (CIK 0001191070)
Date: Nov. 14, 2022 · CIK: 0001191070 · Accession: 0001193125-22-283560
AI Filing Summary & Sentiment
File numbers found in text: 333-268314
Letter
Bionomics Limited
200 Greenhill Road
Eastwood SA
Australia
November 14, 2022
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
Office of Life Sciences
100 F Street N.E.
Washington, D.C. 20549
Attention: Christopher Edwards
Jordan Nimitz
Kevin Vaugh
Christine Wong
Re: Bionomics Limited
Registration Statement on Form F-1
File No. 333-268314
Ladies and Gentlemen:
Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Bionomics Limited (the “Company”), respectfully requests that the effective date of the Registration Statement on Form F-1 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 15, 2022, or as soon as practicable thereafter.
Please contact Michael E. Sullivan of Latham & Watkins LLP, counsel to the Company, at (858) 523-3959, to provide notice of effectiveness, or if you have any questions or require additional information regarding this matter. Thank you for your assistance and cooperation in this matter.
Very truly yours,
BIONOMICS LIMITED
Show Raw Text
CORRESP 1 filename1.htm CORRESP Bionomics Limited 200 Greenhill Road Eastwood SA 5063 Australia November 14, 2022 VIA EDGAR U.S. Securities and Exchange Commission Division of Corporation Finance Office of Life Sciences 100 F Street N.E. Washington, D.C. 20549 Attention: Christopher Edwards Jordan Nimitz Kevin Vaugh Christine Wong Re: Bionomics Limited Registration Statement on Form F-1 File No. 333-268314 Ladies and Gentlemen: Pursuant to Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, the undersigned, on behalf of Bionomics Limited (the “Company”), respectfully requests that the effective date of the Registration Statement on Form F-1 referred to above be accelerated so that it will become effective at 4:00 P.M. Eastern Time on November 15, 2022, or as soon as practicable thereafter. Please contact Michael E. Sullivan of Latham & Watkins LLP, counsel to the Company, at (858) 523-3959, to provide notice of effectiveness, or if you have any questions or require additional information regarding this matter. Thank you for your assistance and cooperation in this matter. Very truly yours, BIONOMICS LIMITED By: /s/ Errol De Souza Errol De Souza, Ph.D. Executive Chairman cc: Michael E. Sullivan, Latham & Watkins LLP Nathaniel Ajiashvili, Latham & Watkins LLP Anthony W. Basch, Kaufman & Canoles, P.C. Yan (Natalie) Wang, Kaufman & Canoles, P.C.